The State of the Art of Treatment for Pediatric and Adolescent ADHD
Medscape News - large, short-term, double-blind, placebo-controlled trials have demonstrated significant reduction of ADHD symptoms study explored atomoxetine treatment for children aged 8 to 17 years who met criteria for both ADHD and either generalized anxiety
Source: www.medscape.com
Click here for more information about overcome anxiety attacks
<< Home